公司资料
PaxMedica 股价、新闻与催化剂
- 股票代码:
- PXMD
- 交易所:
- NASDAQ
- 行业:
- Biopharma
- 所在地:
- United States
股票表现
0.00 USD (+14.29%)
收盘价
最后更新: 2026年8月20日
—
市值
股价为何变动
Current closing-price context is not available for PXMD.
公司概览
业务概览
PaxMedica is a biotechnology company focused on neurodevelopmental disorders and other high-unmet-need conditions. Its story is centered on using a small pipeline to address difficult patient populations.
所在地与行业分类
PaxMedica is headquartered in the United States and listed on NASDAQ. It sits in small-cap biotechnology.
商业模式特征
The company depends on clinical progress, capital efficiency, and the ability to keep a narrow pipeline moving. Investors usually watch early data and whether the company can sharpen its thesis.
生物医药行业定位
PaxMedica occupies a speculative small-cap biotech niche. It is catalyst-sensitive because the company is still proving its therapeutic relevance.
未来催化剂
- PaxMedica’s catalysts are PAX-101 and the neurodevelopment / rare-disease programs, where any update can materially change sentiment. The stock remains highly data-dependent.
近期新闻
相似股票
商业成熟度、治疗领域或催化剂模式相近的同行公司。